Advertisement

Myocardial perfusion imaging by SPECT

  • Ernst E. van der Wall
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 186)

Summary

Over the last decade, substantial advancements in the field of myocardial perfusion scintigraphy have markedly improved the diagnosis and subsequent evaluation of patients with coronary artery disease (CAD). These improvements have mainly originated from the transition of planar imaging to single-photon emission computed tomography (SPECT). In addition, several new technetium 99m (99mTc) based radiopharmaceuticals have entered the clinical arena which are very suitable for SPECT imaging. Lastly, new pharmacological stress agents have been developed. In this era of continuing cost containment, myocardial perfusion scintigraphy using SPECT imaging has emerged as a highly cost-effective noninvasive modality for guiding patient management.

This chapter will concentrate on the merits of SPECT imaging, the use of the appropriate SPECT imaging protocols both for thallium-201 (201Tl) and 99mTc-labeled agents, and the application of pharmacologic stress in myocardial perfusion SPECT imaging.

Keywords

Myocardial Perfusion Myocardial Perfusion Imaging Perfusion Defect SPECT Imaging Myocardial Perfusion Scintigraphy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Verzijlbergen JF, Van Oudheusden D, Cramer MJ et al. Quantitative analysis of planar technetium-99m Sestamibi myocardial perfusion images. Clinical application of a modified method for the subtraction of tissue crosstalk. Eur Heart J 1994;15:1217–26.PubMedGoogle Scholar
  2. 2.
    Kiat H, Berman DS, Maddahi J. Comparison of planar and tomographic exercise thallium-201 imaging methods for the evaluation of coronary artery disease. J Am Coll Cardiol 1989;13:613–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Mahmarian JJ, Pratt CM, Borges-Neto S, Cashion WR, Roberts R, Verani MS. Quantification of infarct size by 201T1-single-photon emission computed tomography during acute myocardial infarction in humans. Comparison with enzymatic estimates. Circulation 1988;78:831–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Mahmarian JJ, Pratt CM, Nishimura S, Abren A, Verani MS. Quantitative adenosine 201T1 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993;87; 1197–210.PubMedGoogle Scholar
  5. 5.
    Wackers FJ, Berman DS, Maddahi J et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:310–11.Google Scholar
  6. 6.
    Zaret BL, Rigo P, Wackers FJT et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201T1 imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995;91:313–9.PubMedGoogle Scholar
  7. 7.
    Berman DS, Hachamovitch R, Kiat H et al.Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–47.PubMedCrossRefGoogle Scholar
  8. 8.
    Kiat H, Berman DS, Maddahi J et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988;12:1456–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Kayden DS, Sigal S, Soufer R, Mattera J, Zaret BL, Wackers FJT. Thallium-201 for assessment of myocardial viability: quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. J Am Coll Cardiol 1991;18:1480–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Dilsizian V, Rocco TP, Freeman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Kuijper AFM, Vliegen HW, van der Wall EE et al. The clinical impact of thallium-201 reinjection scintigraphy for detection of myocardial viability. Eur J Nucl Med 1992;19:783–99.PubMedCrossRefGoogle Scholar
  12. 12.
    Van Eck-Smit BLF, van der Wall EE, Kuijper AFM, Zwinderman AH, Pauwels EKJ. Immediate thallium-201 reinjection following stress imaging: a time-saving approach for detection of myocardial viability. J Nucl Med 1993;34:737–43.PubMedGoogle Scholar
  13. 13.
    Wackers FJ, Pieri PL, McMahon M et al. Quantitative reproducibility of repeated planar thallium stress imaging [abstract]. J Nucl Med 1993;34(5 Suppl):44P.Google Scholar
  14. 14.
    He ZX, Darcourt J, Guignier A et al. Nitrates improve detection of ischemic viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993;34:1472–7.PubMedGoogle Scholar
  15. 15.
    Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630–41.PubMedGoogle Scholar
  16. 16.
    Van Eck-Smit BLF, van der Wall EE, Zwinderman AH, Pauwels EKJ. Clinical value of immediate thallium-201 reinjection imaging for the detection of ischaemic heart disease. Eur Heart J 1995;16:410–20.PubMedGoogle Scholar
  17. 17.
    Van Eck-Smit BLF, van der Wall EE. Reinjection of thallium for detection of viable myocardium: why not do it immediately? Br Heart J 1995;74:101–2.PubMedCrossRefGoogle Scholar
  18. 18.
    Taillefer R, Laflamma L, Dupras G, Picard M, Phaneuf DC, Leveille J. Myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile (MIBI): comparison of short and long time intervals between rest and stress injection. Preliminary results. Eur J Nucl Med 1988;13:515–22.PubMedCrossRefGoogle Scholar
  19. 19.
    Taillefer R. Technetium-99m sestamibi myocardial imaging: same-day rest stress studies and dipyridamole. Am J Cardiol 1990;66:80E–84E.PubMedCrossRefGoogle Scholar
  20. 20.
    Verzijlbergen JF, Suttorp MJ, Ascoop CAPL et al. Combined assessment of technetium-99m sestamibi planar myocardial perfusion images at rest and during exercise with rest-exercise left ventricular wall motion studies evaluated from gated myocardial perfusion studies. Am Heart J 1992;123:59–68.PubMedCrossRefGoogle Scholar
  21. 21.
    Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989;14:1678–84.PubMedCrossRefGoogle Scholar
  22. 22.
    Berman DS, Kiat H, Friedman JD et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455–64.PubMedCrossRefGoogle Scholar
  23. 23.
    Seldin DW, Johnson LL, Blood DK et al. Myocardial perfusion imaging with technetium SQ30217: comparison with thallium-201 and coronary anatomy. J Nucl Med 1989;30:312–9.PubMedGoogle Scholar
  24. 24.
    Hendel RC, McSherry B, Karimeddini M, Leppo JA. Diagnostic value of a new myocardial perfusion agent, teboroxime (SQ 30,217), utilizing a rapid planar imaging protocol: preliminary results. J Am Coll Cardiol 1990;16:855–61.PubMedCrossRefGoogle Scholar
  25. 25.
    Chua T, Kiat H, Germano G et al. Rapid back to back adenosine stress/rest technetium-99m teboroxime myocardial perfusion SPECT using a triple-detector camera. J Nucl Med 1993;34:1485–93.PubMedGoogle Scholar
  26. 26.
    Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99M-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254–9.PubMedGoogle Scholar
  27. 27.
    Sridhara BS, Braat S, Rigo P, Itti P, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m-tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72:1015–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Mahmarian JJ, Pratt CM, Boyce TM, Verani MS. The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography. J Am Coll Cardiol 1991;17:355–62.PubMedCrossRefGoogle Scholar
  29. 29.
    Verzijlbergen JF, Cramer MJ, Niemeyer MG, Ascoop CA, van der Wall EE, Pauwels EK. 99Tcm-SESTAMIBI for planar myocardial perfusion imaging;not as ideal as the physical properties. Nucl Med Commun 1991;12:381–91.PubMedCrossRefGoogle Scholar
  30. 30.
    Cramer MJ, Verzijlbergen JF, van der Wall EE et al. Head-to-head comparison between technetium-99m-sestamibi and thallium-201 tomographic imaging for the detection of coronary artery disease using combined dipyridamole-exercise-stress. Coron Artery Dis 1994;5:787–91.PubMedGoogle Scholar
  31. 31.
    Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. J Am Coll Cardiol 1991;18:736–45.PubMedCrossRefGoogle Scholar
  32. 32.
    Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583–90.PubMedCrossRefGoogle Scholar
  33. 33.
    Marwick T, Willemart B, D’Hondt AM et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 1993;87:345–54.PubMedGoogle Scholar
  34. 34.
    Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991;83:363–81.PubMedGoogle Scholar
  35. 35.
    Oosterhuis WP, Breeman A, Niemeyer MG et al. Patients with a normal exercise thallium-201 myocardial scintigram: always a good prognosis? Eur J Nucl Med 1993;20:151–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665–70.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Ernst E. van der Wall

There are no affiliations available

Personalised recommendations